These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19637729)

  • 1. [Contraconception in women with systemic lupus erythematosus].
    Cravioto Mdel C; Durand-Carbajal M; Sánchez-Guerrero J
    Rev Invest Clin; 2009; 61(2):150-9; discussion 159-60. PubMed ID: 19637729
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contraception: methods, contraindications, surveillance].
    Lopes P; Mensier A
    Rev Prat; 2000 Feb; 50(4):451-60. PubMed ID: 10748681
    [No Abstract]   [Full Text] [Related]  

  • 3. Contraception for women: an evidence based overview.
    Amy JJ; Tripathi V
    BMJ; 2009 Aug; 339():b2895. PubMed ID: 19666684
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic lupus erythematosus (SLE): sexual hormones, contraception and pregnancy].
    Vanini G; Chizzolini C
    Rev Med Suisse; 2005 Apr; 1(15):991-4. PubMed ID: 15918278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contraception. Method, efficacy, choice, contra-indications, monitoring, risk].
    Mensier A; Lopes P
    Rev Prat; 1996 Jan; 46(1):119-28. PubMed ID: 8596885
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
    van Vliet HA; Tchaikovski SN; Rosendaal FR; Rosing J; Helmerhorst FM
    Thromb Haemost; 2009 Apr; 101(4):691-5. PubMed ID: 19350113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term contraceptives.
    Brown A
    Best Pract Res Clin Obstet Gynaecol; 2010 Oct; 24(5):617-31. PubMed ID: 20558111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based approach to hormonal contraception and headaches.
    Harris M; Kaneshiro B
    Contraception; 2009 Nov; 80(5):417-21. PubMed ID: 19835714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renewed interest in haemostasis changes induced by oral contraceptives (OCs).
    Kluft C
    Thromb Haemost; 2000 Jul; 84(1):1-3. PubMed ID: 10928460
    [No Abstract]   [Full Text] [Related]  

  • 13. Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Sammaritano LR
    Lupus; 2014 Oct; 23(12):1242-5. PubMed ID: 25228715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of contraceptives.
    Med Lett Drugs Ther; 2015 Sep; 57(1477):127-32. PubMed ID: 26353044
    [No Abstract]   [Full Text] [Related]  

  • 15. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
    Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract]   [Full Text] [Related]  

  • 18. ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives.
    Merki-Feld GS; Apter D; Bartfai G; Grandi G; Haldre K; Lech M; Lertxundi R; Lete I; Lobo Abascal P; Raine S; Roumen F; Serfaty D; Shulman LP; Skouby S; Bitzer J
    Eur J Contracept Reprod Health Care; 2017 Aug; 22(4):247-249. PubMed ID: 28728451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects unrelated to disease activity and acceptability of highly effective contraceptive methods in women with systemic lupus erythematosus: a randomized, clinical trial.
    Cravioto MD; Jiménez-Santana L; Mayorga J; Seuc AH
    Contraception; 2014 Aug; 90(2):147-53. PubMed ID: 24815101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [item 117--Disseminated lupus erythematosus: antiphospholipid syndrome].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A102-11. PubMed ID: 23176830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.